MA33375B1 - Procédé de préparation de l'ibodutant (men15596) et intermédiaires apparentés - Google Patents
Procédé de préparation de l'ibodutant (men15596) et intermédiaires apparentésInfo
- Publication number
- MA33375B1 MA33375B1 MA34472A MA34472A MA33375B1 MA 33375 B1 MA33375 B1 MA 33375B1 MA 34472 A MA34472 A MA 34472A MA 34472 A MA34472 A MA 34472A MA 33375 B1 MA33375 B1 MA 33375B1
- Authority
- MA
- Morocco
- Prior art keywords
- ibodutant
- men15596
- preparing
- alpha
- coupling
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4433—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Compounds Of Unknown Constitution (AREA)
- Steroid Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
La présente invention concerne un nouveau procédé de synthèse du produit nommé ibodutant présenté sur la figure ci-jointe, constitué de peu d'étapes à haut rendement faisant intervenir des réactifs et des solvants présentant un faible impact sur l'environnement. Ledit procédé est caractérisé par le couplage de deux parties, à savoir les composés (3) et (4), l'un d'eux (3) étant synthétisé par couplage de l'acide 6-méthyl-2-benzo[b]thiophènecarboxylique (1) avec l'acide 1-amino-alpha-alpha-cyclopentanecarboxylique et cyclisation ultérieure avec l'oxazolone, tandis que l'autre, le composé (4), est obtenu à partir de fonctionnalisations hautement sélectives appropriées de la 4-aminométhylpipéridine (2).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI2009A000897A IT1394304B1 (it) | 2009-05-21 | 2009-05-21 | Processo per la preparazione di ibodutant (men15596) e relativi intermedi |
| PCT/EP2010/002884 WO2010133306A1 (fr) | 2009-05-21 | 2010-05-11 | Procédé de préparation de l'ibodutant (men15596) et intermédiaires apparentés |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA33375B1 true MA33375B1 (fr) | 2012-06-01 |
Family
ID=41264221
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA34472A MA33375B1 (fr) | 2009-05-21 | 2010-05-11 | Procédé de préparation de l'ibodutant (men15596) et intermédiaires apparentés |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US8431684B2 (fr) |
| EP (1) | EP2432778B1 (fr) |
| JP (1) | JP5645926B2 (fr) |
| KR (1) | KR101695346B1 (fr) |
| CN (1) | CN102428081B (fr) |
| AR (1) | AR076785A1 (fr) |
| AU (1) | AU2010251514B2 (fr) |
| BR (1) | BRPI1013073A2 (fr) |
| CA (1) | CA2762625A1 (fr) |
| CY (1) | CY1114079T1 (fr) |
| DK (1) | DK2432778T3 (fr) |
| EA (1) | EA019777B1 (fr) |
| EG (1) | EG27000A (fr) |
| ES (1) | ES2409705T3 (fr) |
| HK (1) | HK1169828A1 (fr) |
| HR (1) | HRP20130380T1 (fr) |
| IL (1) | IL216400A (fr) |
| IT (1) | IT1394304B1 (fr) |
| MA (1) | MA33375B1 (fr) |
| MX (1) | MX2011012317A (fr) |
| NZ (1) | NZ596523A (fr) |
| PL (1) | PL2432778T3 (fr) |
| PT (1) | PT2432778E (fr) |
| SG (1) | SG176171A1 (fr) |
| SI (1) | SI2432778T1 (fr) |
| TW (1) | TWI424996B (fr) |
| UA (1) | UA105523C2 (fr) |
| WO (1) | WO2010133306A1 (fr) |
| ZA (1) | ZA201108483B (fr) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY130373A (en) * | 2001-10-29 | 2007-06-29 | Malesci Sas | Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| ITFI20040221A1 (it) * | 2004-10-27 | 2005-01-27 | Guidotti & C Spa | Composizioni farmaceutiche a base di nk2 antagonisti per uso pediatrico |
| US8829209B2 (en) * | 2006-01-11 | 2014-09-09 | Seikagaku Corporation | Cycloalkylcarbonylamino acid ester derivative and process for producing the same |
-
2009
- 2009-05-21 IT ITMI2009A000897A patent/IT1394304B1/it active
-
2010
- 2010-05-11 KR KR1020117027585A patent/KR101695346B1/ko active IP Right Grant
- 2010-05-11 BR BRPI1013073A patent/BRPI1013073A2/pt not_active IP Right Cessation
- 2010-05-11 PL PL10721687T patent/PL2432778T3/pl unknown
- 2010-05-11 PT PT107216871T patent/PT2432778E/pt unknown
- 2010-05-11 NZ NZ596523A patent/NZ596523A/xx not_active IP Right Cessation
- 2010-05-11 MA MA34472A patent/MA33375B1/fr unknown
- 2010-05-11 UA UAA201113614A patent/UA105523C2/uk unknown
- 2010-05-11 CA CA2762625A patent/CA2762625A1/fr not_active Abandoned
- 2010-05-11 ES ES10721687T patent/ES2409705T3/es active Active
- 2010-05-11 SG SG2011085545A patent/SG176171A1/en unknown
- 2010-05-11 WO PCT/EP2010/002884 patent/WO2010133306A1/fr active Application Filing
- 2010-05-11 MX MX2011012317A patent/MX2011012317A/es active IP Right Grant
- 2010-05-11 SI SI201030192T patent/SI2432778T1/sl unknown
- 2010-05-11 US US13/321,501 patent/US8431684B2/en not_active Expired - Fee Related
- 2010-05-11 CN CN201080021722.5A patent/CN102428081B/zh not_active Expired - Fee Related
- 2010-05-11 EA EA201190267A patent/EA019777B1/ru not_active IP Right Cessation
- 2010-05-11 AU AU2010251514A patent/AU2010251514B2/en not_active Ceased
- 2010-05-11 JP JP2012511171A patent/JP5645926B2/ja not_active Expired - Fee Related
- 2010-05-11 EP EP10721687A patent/EP2432778B1/fr active Active
- 2010-05-11 DK DK10721687.1T patent/DK2432778T3/da active
- 2010-05-20 AR ARP100101759A patent/AR076785A1/es unknown
- 2010-05-20 TW TW099116060A patent/TWI424996B/zh not_active IP Right Cessation
-
2011
- 2011-11-17 IL IL216400A patent/IL216400A/en not_active IP Right Cessation
- 2011-11-17 EG EG2011111951A patent/EG27000A/xx active
- 2011-11-18 ZA ZA2011/08483A patent/ZA201108483B/en unknown
-
2012
- 2012-10-24 HK HK12110578.5A patent/HK1169828A1/xx not_active IP Right Cessation
-
2013
- 2013-05-02 HR HRP20130380AT patent/HRP20130380T1/hr unknown
- 2013-05-16 CY CY20131100392T patent/CY1114079T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2006004100A8 (fr) | Procédé pour la fabrication d’un composé de 1,2-dihydropyridine-2-one | |
| JP2005522440A5 (fr) | ||
| WO2009066735A1 (fr) | Procédé de production de 2-azaadamantane | |
| WO2007119118A3 (fr) | Synthèse améliorée et préparations d'intermédiaires et de nouveaux polymorphes correspondants utilisés dans la production de chlorhydrate de donépézil | |
| CA2360033A1 (fr) | Procede de preparation de n-carboxyanhydrides | |
| WO2007018807A3 (fr) | Procedes et produits intermediaires pour la synthese de porphyrines | |
| WO2005085243A3 (fr) | Nouveau procede de production de la cabergoline | |
| WO2008081726A1 (fr) | Procédé de fabrication d'un amide ou d'un lactame | |
| AU2001254998A1 (en) | Process for the synthesis of a known tetrazol derivative | |
| AU6474200A (en) | Process for the preparation of a pyridinemethanol compound | |
| DE602006004403D1 (de) | Verfahren zur Herstellung von Carvedilol | |
| WO2006098855A3 (fr) | Procedes de preparation de morphinanes et de produits intermediaires de ceux-ci | |
| MA33375B1 (fr) | Procédé de préparation de l'ibodutant (men15596) et intermédiaires apparentés | |
| WO2003048131A1 (fr) | Intermediaire destine a la biotine et procede de production associe | |
| TW200740763A (en) | A method for preparing 5-hydroxy-1-alkyl pyrazole derivatives | |
| WO2005063731A3 (fr) | Production de dihydronepetalactone par reduction de l'acide nepetalique | |
| WO2006043175A3 (fr) | Procede de preparation de composes puriques | |
| CN1105996A (zh) | 咪唑并吡啶类衍生物的制备方法 | |
| WO2004039776A3 (fr) | Procede de preparation de derives de l'azetidine | |
| EP1623975A4 (fr) | Procede de production de derives de pyrrolidine | |
| WO2010007121A3 (fr) | Procédé de production de composés de 1,3,2-dioxaborinane | |
| WO2005090310A3 (fr) | Procede pour la preparation de monoamide de l'acide cyclohexanediacetique | |
| WO2005107374A3 (fr) | Procede pour la preparation d'un derive d'acide 1,4-dihydropyridine-3,5-dicarboxylique | |
| WO2008062480A3 (fr) | Procédé amélioré de préparation du rimonabant | |
| WO2005095394A8 (fr) | Procedaient pour la synthese de la deserpidine |